Cargando…
EGFR-TKIs治疗晚期非小细胞肺癌获益后出现缓慢进展的治疗选择：附32例病例总结
BACKGROUND AND OBJECTIVE: The epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been widely used in the treatment of the advanced non-small cell lung cancer (NSCLC), especially in the adenocarcinoma patients with activating EGFR mutations. But there is no published overvie...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015169/ https://www.ncbi.nlm.nih.gov/pubmed/24113005 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.05 |